ArticleJournal for immunotherapy of cancerPublished
Novel tri-specific T-cell engager targeting IL-13Rα2 and EGFRvIII provides long-term survival in heterogeneous GBM challenge and promotes antitumor cytotoxicity with patient immune cells
Regional connection
Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- Journal for immunotherapy of cancer
- Published
- Topic
- Disease research
- Subject terms
- T-Lymphocytes; Cell Line, Tumor; Animals; Mice, Inbred NOD; Humans; Mice; Mice, SCID; Glioblastoma; Brain Neoplasms; Immunotherapy; Xenograft Model Antitumor Assays; Female
- PubMed ID
- 39622583
- PubMed Central ID
- PMC11624777
- Open access
- Yes, open
- Added to directory
- Source checked